Researchers at Stanford are developing methods of using arginine vasopressin (AVP) to improve social abilities of children with autism spectrum disorder (ASD). Autism is a neurodevelopmental disorder characterized by social impairments (e.g.
Researchers in Prof. Karen Parker's laboratory have discovered a biomarker that could enable an objective laboratory-based test for diagnosing autism spectrum disorders (ASD) and predicting the severity of a patient's symptoms.